Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 8, 2012, Pages 1077-1081

  Sudarshan, Mysore Kalappa ^a   Narayana, Doddabele Hanumanthaiah Ashwath ^a   Madhusudana, Shampur Narayan ^b   Holla, Ramesh ^a   Ashwin, Belludi Yajaman ^b   Gangaboraiah, Bilagumba ^a   Ravish, Haradanahalli S ^a  

^a KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Intradermal rabies vaccination; Purified chick embryo cell rabies vaccine; Purified vero cell rabies vaccine; Rabies; Randomized controlled trial

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INCIDENCE; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MYALGIA; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; POST EXPOSURE PROPHYLAXIS; PRURITUS; RABIES; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VACCINATION;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DRUG TOXICITY; FEMALE; HUMAN EXPERIMENTATION; HUMANS; IMMUNOLOGIC MEMORY; INCIDENCE; INDIA; INJECTIONS, INTRADERMAL; MALE; NEUTRALIZATION TESTS; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RABIES VIRUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866084929     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20471     Document Type: Article

References (18)

1. WHO expert consultation on rabies. First report. WHO Technical Report series 931, Geneva 2005; 3-4.
2. Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine 2007; 25:7605-9; PMID:17905484; http://dx.doi.org/10.1016/j.vaccine.2007.08.054.
3. Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010; 50:56-60; PMID:19995217; http://dx.doi.org/10.1086/649211.
4. World Health Organization. Human and dog rabies prevention and control, Report of the WHO/Bill and Melinda Gates Foundation Consultation, Annecy, France 2009; 20.
5. Bahmanyar M, Fayaz A, Nour-Salehi S, Mohammadi M, Koprowski H. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 1976; 236:2751-4; PMID:1036566; http://dx.doi.org/10.1001/jama.1976.03270250019017.
6. Centers for Disease Control and Prevention. Use of a reduced (4-dose) vaccine schedule for post exposure prophylaxis to prevent human rabies. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2010; 59:1-9.
7. th report. Technical Report Series No. 824. Geneva 1992; 10.
8. National Institute of communicable Diseases: National guidelines for rabies prophylaxis and intradermal administration of cell culture rabies vaccines, New Delhi 2007; 14.
9. Mahendra BJ, Harish BR, Vinay M. A study of factors influencing compliance to IDRV at anti-rabies clinic of Mandya Institute of Medical Sciences, Mandya. APCRI Journal 2009; 11:18-20.
10. Jesha M, Martin J, Bina T, Raphel L. Lailabi, Jayadev. Compliance to IDRV at the anti rabies clinic in a tertiary care hospital in North Kerala. APCRI Journal 2011; 12:21-4.
11. Thraenhart O, Marcus I, Scheiermann N. 3-1 scheme, a regimen of only two clinic visits with optimal antibody and interferon-induction. Progress in rabies control. Kent, England: Wells Medical 1989; 536-47.
12. Khawplod P, Wilde H, Tepsumethanon S, Limusanno S, Tantawichien T, Chomchey P, et al. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Clin Infect Dis 2002; 35:1562-5; PMID:12471579; http://dx.doi.org/10.1086/344954.
13. Sampath G, Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, et al. Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine. Vaccine 2010; 28:4086-90; PMID:20403351; http://dx.doi.org/10.1016/j.vaccine.2010.03.064.
14. Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000; 78:693-8; PMID:10859864.
15. Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Ashwath Narayana DH, Giri A, et al. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Hum Vaccin 2006; 2:200-4; PMID:17035734; http://dx.doi.org/10.4161/hv.2.5.3197.
16. Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine 2006; 24:4116-21; PMID:16545510; http://dx.doi.org/10.1016/j. vaccine.2006.02.036.
17. Ashwathnarayana DH, Madhusudana SN, Sampath G, Satapathy DM, Mankeshwar R, Ravish HS, et al. A comparative study on the safety and immunogenicity of purified duck embryo cell rabies vaccine (PDEV, Vaxirab) with purified chick embryo cell rabies vaccine (PCECV, Rabipur) and purified vero cell rabies vaccine (PVRV, Verorab). Vaccine 2009; 28:148-51; PMID:19818720; http://dx.doi.org/10.1016/j.vaccine.2009.09.090.
18. Madhusudana SN, Anand NP, Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Int J Infect Dis 2002; 6:210-4; PMID:12718837; http://dx.doi.org/10.1016/S1201-9712(02)90113-X.